WAVE Life Sciences Ltd. is a WAVE Life Sciences Ltd is a preclinical biopharmaceutical company based in Singapore.
WAVE Life Sciences Ltd. (WVE) had a good day on the market for Tuesday December 08 as shares jumped 2.67% to close at $8.85. About 490,630 shares traded hands on 4,609 trades for the day, compared with an average daily volume of n/a shares out of a total float of 48.78 million. After opening the trading day at $8.56, shares of WAVE Life Sciences Ltd. stayed within a range of $9.05 to $8.50.
With today’s gains, WAVE Life Sciences Ltd. now has a market cap of $431.68 million. Shares of WAVE Life Sciences Ltd. have been trading within a range of $39.98 and $6.62 over the last year, and it had a 50-day SMA of $n/a and a 200-day SMA of $n/a.
WAVE Life Sciences Ltd is a preclinical biopharmaceutical company based in Singapore. It owns a diverse pipeline of nucleic acid therapeutics meant to address rare genetic diseases related to the central nervous system, muscles, eyes, liver, and skin. Its nucleic acid therapeutics target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins.
WAVE Life Sciences Ltd. is based out of Singapore, and has some 301 employees. Its CEO is Paul B. Bolno.